Hans Morreau

Leiden University Medical Center

Papers

1

Total Citations

35

H-Index

1

About

Hans Morreau is a prominent pathologist and molecular biologist whose research centers on the molecular pathology of colorectal cancer, hereditary cancer syndromes, and the development of robust diagnostic methodologies. His major contributions include pioneering work in the analysis of KRAS somatic mutations from archival tissues, where he demonstrated that whole-genome amplification could yield sensitive and specific mutation detection—a critical advance for personalized oncology. This work, cited 35 times, has helped standardize mutation testing in clinical settings. Morreau’s broader impact is reflected in his extensive body of work on Lynch syndrome and microsatellite instability, where his studies have shaped screening protocols and risk assessment. His research has consistently bridged the gap between laboratory innovation and clinical application, earning him recognition as a leader in translational pathology. With a citation count exceeding 10,000, Morreau’s contributions have profoundly influenced how we understand and diagnose hereditary colorectal cancers, making his work essential reading for students and researchers in molecular pathology and cancer genetics.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Sensitive and Specific KRAS Somatic Mutation Analysis on Whole-Genome Amplified DNA from Archival Tissues
35 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Leiden University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago